Cribstone Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $7.08K | Hold |
153
| – | – | ﹤0.01% | 281 |
|
|
2022
Q3 | $6K | Sell |
153
-207
| -58% | -$8.12K | ﹤0.01% | 285 |
|
|
2022
Q2 | $13K | Buy |
360
+107
| +42% | +$3.86K | 0.01% | 240 |
|
|
2022
Q1 | $11K | Hold |
253
| – | – | 0.01% | 261 |
|
|
2021
Q4 | $11K | Hold |
253
| – | – | 0.01% | 261 |
|
|
2021
Q3 | $11K | Hold |
253
| – | – | 0.01% | 247 |
|
|
2021
Q2 | $11K | Hold |
253
| – | – | 0.01% | 256 |
|
|
2021
Q1 | $10K | Hold |
253
| – | – | 0.01% | 247 |
|
|
2020
Q4 | $9K | Hold |
253
| – | – | 0.01% | 249 |
|
|
2020
Q3 | $10K | Hold |
253
| – | – | 0.01% | 201 |
|
|
2020
Q2 | $9K | Hold |
253
| – | – | 0.01% | 221 |
|
|
2020
Q1 | $8K | Sell |
253
-55
| -18% | -$1.74K | 0.01% | 221 |
|
|
2019
Q4 | $14K | Sell |
308
-30
| -9% | -$1.36K | 0.01% | 235 |
|
|
2019
Q3 | $14K | Sell |
338
-116
| -26% | -$4.81K | 0.01% | 378 |
|
|
2019
Q2 | $20K | Hold |
454
| – | – | 0.01% | 356 |
|
|
2019
Q1 | $17K | Buy |
454
+30
| +7% | +$1.12K | 0.01% | 386 |
|
|
2018
Q4 | $15K | Hold |
424
| – | – | 0.01% | 406 |
|
|
2018
Q3 | $16K | Hold |
424
| – | – | 0.01% | 434 |
|
|
2018
Q2 | $14K | Hold |
424
| – | – | 0.01% | 454 |
|
|
2018
Q1 | $12K | Buy |
424
+116
| +38% | +$3.28K | 0.01% | 472 |
|
|
2017
Q4 | $8K | Hold |
308
| – | – | ﹤0.01% | 598 |
|
|
2017
Q3 | $9K | Hold |
308
| – | – | ﹤0.01% | 514 |
|
|
2017
Q2 | $9K | Hold |
308
| – | – | ﹤0.01% | 503 |
|
|
2017
Q1 | $8K | Hold |
308
| – | – | ﹤0.01% | 547 |
|
|
2016
Q4 | $7K | Hold |
308
| – | – | ﹤0.01% | 538 |
|
|
2016
Q3 | $7K | Hold |
308
| – | – | ﹤0.01% | 540 |
|
|
2016
Q2 | $7K | Buy |
+308
| New | +$7K | ﹤0.01% | 568 |
|